论文部分内容阅读
目的观察阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的临床效果。方法选取收治的肺炎支原体肺炎的患儿120例为研究对象,随机分为观察组和对照组,每组60例。观察组采用阿奇霉素联合孟鲁司特钠咀嚼片治疗,对照组采用红霉素联合孟鲁司特钠咀嚼片治疗,2组均给予对症处理。观察比较2组患儿的临床疗效、不良反应发生率。结果观察组总有效率为93.33%,高于对照组的76.67%,差异有统计学意义(P<0.05)。观察组不良反应发生率为8.33%,低于对照组的36.67%,差异有统计学意义(P<0.05)。结论阿奇霉素联合孟鲁司特钠咀嚼片治疗小儿肺炎支原体肺炎的效果较优,值得临床上推广应用。
Objective To observe the clinical effect of azithromycin and montelukast sodium in the treatment of Mycoplasma pneumoniae pneumonia in children. Methods A total of 120 children with Mycoplasma pneumoniae pneumonia were selected as study subjects and randomly divided into observation group and control group, with 60 cases in each group. The observation group was treated with azithromycin combined with montelukast sodium chewable tablets. The control group was treated with erythromycin combined with montelukast sodium chewable tablets. Both groups were given symptomatic treatment. The clinical efficacy and the incidence of adverse reactions in the two groups were observed and compared. Results The total effective rate in observation group was 93.33%, which was higher than that in control group (76.67%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 8.33%, which was lower than that in the control group (36.67%), the difference was statistically significant (P <0.05). Conclusion Azithromycin combined with montelukast sodium chewable tablets in children with Mycoplasma pneumoniae pneumonia better effect, it is worth promoting the clinical application.